News Image

Henry Schein and Biomerica Enter into Marketing Services Agreement for Biomerica’s inFoods® IBS Test in the U.S.

Provided By GlobeNewswire

Last update: Oct 16, 2025

- Expands Marketing of Non-Drug IBS Symptom Management Test Through One of the Nation’s Most Trusted Health Care Distributors
- Relationship Marks a Key Milestone in Biomerica’s Commercialization Strategy

Read more at globenewswire.com

BIOMERICA INC

NASDAQ:BMRA (11/7/2025, 8:00:02 PM)

After market: 2.3349 -0.13 (-5.09%)

2.46

-0.09 (-3.53%)



Find more stocks in the Stock Screener

Follow ChartMill for more